(Video length 00:03:55)
Joseph Wolk, Johnson & Johnson CFO, breaks down the company's quarterly numbers which beat on the top and bottom line, helped by improved cancer drug sales.
Johnson & Johnson CFO, breaks down the company's quarterly numbers which beat on the top and bottom line, helped by improved cancer drug sales.
(Video length 00:03:55)
Joseph Wolk, Johnson & Johnson CFO, breaks down the company's quarterly numbers which beat on the top and bottom line, helped by improved cancer drug sales.
Comments
Log in or sign up to join the conversation.